CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocoldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02896361
NCT02896361N/ACompleted
CompareCT.gov

Burst Optimized Stimulation Study

Abbott Medical Devices·interventional·Posted Sep 12, 2016·Updated May 30, 2019

In Brief

A clinical study evaluating Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol for Chronic Pain. Completed, enrolled 29 participants across 3 sites in 2 countries.

Detailed Summary

This purpose of this study is to evaluate the therapeutic efficacy of burst microdosing stimulation paradigms in patients with chronic pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesBelgium, Germany
CollaboratorsMedizinische Einrichtungen der Universität Düsseldorf, Klinikum Duisburg GmbH, NKO Sint-Augustinus Antwerpen

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 12, 2016
Enrollment StartJul 1, 2016
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.8 years ago

Interventions

Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocoldevice

Stimulation parameters are reprogrammed from original values to study defined ones